Molecular Iodine: A New Frontline Defense Against COVID19

Presented by Dr. Herb Moskowitz
Recorded On Demand Webinar

TITLE:  AN ANALYSIS OF ANTIMICROBIAL ORAL RINSES IN DENTAL PRACTICES TO ADVANCE SAFETY AND EFFICACY DURING A PANDEMIC.

 

MOLECULAR IODINE - A NEW FRONTLINE DEFENSE AGAINST COVID19

COURSE FEE:  Free

DOWNLOAD HANDOUTS & CITATIONS HERE: https://drive.google.com/drive/folders/1jPsSYj3y1qfrBhFZkKLsZYP6EMsZIwr9?usp=sharing

CREDITS: This continuing education activity is designated for 2 credits

AGD PACE SUBJECT CODE:  010 Basic Sciences. Pharmacotherapeutics, Emerging Technology

MODE: Self-study. Recorded Webinar.

RELEASED:  April 14, 2021             EXPIRES:  September 30, 2021

SPEAKER: Dr. Herb Moskowitz. Scroll down to see bio.

AUDIENCE: Dentists, Dental Hygienists, Dental Therapists, Dental Assistants

TECHNOLOGY REQUIRED:  Mobile device, laptop or desktop with internet connection | Google Chrome Browser

COURSE SUMMARY:  A new generation of super-iodines is being developed with proven anti-virucidal activity against SARS-CoV-2. This course will analyze the efficacy and safety of current anti-microbial rinses and introduce the latest generation of rinses under development. Upon the completion of this webinar, you will be provided with evidence-based studies showing the most effective rinses to protect both patients and staff.

LEARNING OBJECTIVES: 

  1. Review the evolution of iodine in becoming a standard of care.

  2. Learn about a technological breakthrough leading to a new class of “super” iodines​.

  3. Compare the efficacy of commonly used oral rinses against SARS-CoV-2.

  4. Understand how the implementation of the new “super” iodines in your practice will benefit your patients.

  5. Compare the advantages and disadvantages of commonly used oral rinses.

  6. Describe the misconceptions related to iodine sensitivity.

  7. Learn why periodontal bacteremias are now considered a cause of cardiovascular disease.

Disclosure of Speaker and Faculty Commercial Relationships: According to Dental CE Academy's  Conflict of Interest and Disclosure Policy, faculty and speakers for any course are expected to disclose any economic support, personal interests, or potential bias that may be perceived as creating a conflict related to the material being presented. Disclosure statements are printed in each course description and announced by moderators or individual speakers at the beginning of each presentation. This policy is intended to alert the audience to any potential bias or conflict so that participants may form their own judgments about the material being presented.

Conflict of Interest and Financial Disclosure of Speaker:  Dr. Herb Moskowitz, DDS; is the Chairman and Co-Founder of ioTech International. He is a paid speaker and has a financial interest in ioTech International.

Dental CE Academy Disclaimer:  The views expressed and opinions and materials presented during these live and recorded presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy or its parent company, Virtual Dontics®. Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based upon the speaker's own clinical experience and should not be construed as Dental CE Academy recommended or endorsed. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to interest and scientific breakthroughs in the fields of dentistry.    Dental CE Academy appreciates its educators who share their knowledge and expertise. This level of dedication to dentistry allows our profession to expand and thrive and provokes necessary discussion and understanding. 

 

Herb Moskowitz ioTech headshot 5.5.19.jp

About the Speaker: Dr. Herb Moskowitz is the Chairman and Co-Founder of ioTech International. He is the co-author of ioTech's U.S. patent and global patent applications. He previously founded and served as Chairman and CEO of Advanced Tissue Sciences and Life Medical Sciences, two publicly traded medical technology companies. He has also practiced clinical dentistry for more than 25 years and is a graduate of the University of Tennessee Dental School.